Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse (Q23917574)

5

object named as

Donna Wilcock

0 references

author name string

Marcia N. Gordon

1

0 references

Leigh A. Holcomb

2

0 references

Paul T. Jantzen

3

0 references

Giovanni DiCarlo

4

0 references

Kristal W. Boyett

6

0 references

Karen Connor

7

0 references

Jason Melachrino

8

0 references

Dave Morgan

on focus list of Wikimedia project

10

0 references

language of work or name

English

0 references

publication date

February 2002

0 references

published in

Experimental Neurology

0 references

volume

173

0 references

issue

2

0 references

page(s)

183-195

0 references

Wikimedia–NIOSH collaboration

0 references

2 references

2 February 2024

inferred from physical address

cites work

Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Functional phenotype in transgenic mice expressing mutant human presenilin-1.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Association of microglia with amyloid plaques in brains of APP23 transgenic mice

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Targeting alzheimer amyloid plaques in vivo

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Amyloid Precursor Protein (APP) in the Striatum in Alzheimerʼs Disease: An Immunohistochemical Study

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021

The pathogenesis and progression of the pathological changes of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1006%2FEXNR.2001.7754

7 January 2021